RxREVU

RxREVU raises $3M for its medication optimization solution

The company has developed a next generation prescription decision support at the point of care to help large health systems reduce costs and improve outcomes.
Teladoc

Teladoc ended 2015 with 12.2M members, revenues of $77 million

Fourth quarter revenues of $23M represent a Y-o-Y increase of 75%; meanwhile the number of visits increased 67% to 184,000 in the quarter.
Medlanes

German startup Medlanes raises money from AXA Strategic Ventures

The company has developed an artificial intelligence technology that provides initial medical diagnosis from a simple photo and a description of symptoms.
Proteus Digital Health

Chinese drug maker to invest $40M in Proteus Digital Health

As part of the deal, Gloria will also get an 18-month period of exclusive negotiation with Proteus to establish a joint venture company in China.
Valencell BioPack

Valencell raises $11M Series D for its biometric sensor tech

The company will use the funds to continue its growth and support further innovation in accurate biometric wearable technology.
Eight sleep

Eight gets $6M for its sleep tracking tech

The company will use the funds to accelerate production, develop new products, and finance growth initiatives; Eight will start shipping in early spring 2016.
POPS! Diabetes Care

POPS! Diabetes Care raises $500K for its diabetes management solution

The company is developing a mobile solution for patients with diabetes to better self-manage, and for healthcare providers to expand their reach to patients.
MyDario

LabStyle raises $8.5M in a public offering

The company will use the funds to increase manufacturing capacity, further develop its Dario Diabetes Management Solution, expand sales and marketing efforts.
Verio Flex

LifeScan, WellDoc team-up to advance mobile care for Type 2 diabetes patients

The two companies will integrate LifeScan's OneTouch Verio Flex blood glucose monitoring system with WellDoc's BlueStar diabetes management platform.
HealthCatalyst

Health Catalyst gets $70M to expand its outcomes improvement solutions

The Series E round was co-led by Norwest Venture Partners, the lead investor in three previous rounds, and UPMC, an existing Health Catalyst customer.